The immune suppressive function of transforming growth factor-β (TGF-β) in human diseases

References

• Ahn J-Y, Kim M-H, Lim M-J, Park S, Lee S-L-O, Yun Y-S, Song J-Y. 2011. The inhibitory effect of ginsan on TGF-β mediated fibrotic process. J Cell Physiol 226:1241–1247
   PubMed Web of Science ®Google Scholar
• Allen JB, Manthey CL, Hand AR, Ohura K, Ellingsworth L, Wahl SM. 1990. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta. J Exp Med 171:231–247
   PubMed Web of Science ®Google Scholar
• Anaya JM. 2012. Common mechanisms of autoimmune diseases (the autoimmune tautology). Autoimmun Rev 11:781–784
   PubMed Web of Science ®Google Scholar
• Annes JP, Munger JS, Rifkin DB. 2003. Making sense of latent TGFβ activation. J Cell Sci 116:217–224
   PubMed Web of Science ®Google Scholar
• Bakkebø M, Huse K, Hilden VI, Smeland EB, Oksvold MP. 2010. TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK. BMC Immunol 11:57–57
   PubMed Web of Science ®Google Scholar
• Becker-Merok A, Eilertsen GØ, Nossent JC. 2010. Levels of transforming growth factor-β are low in systemic lupus erythematosus patients with active disease. J Rheumatol 37:2039–2045
   PubMed Web of Science ®Google Scholar
• Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238
   PubMed Web of Science ®Google Scholar
• Bournia VKK, Vlachoyiannopoulos PG, Selmi C, Moutsopoulos HM, Gershwin ME. 2009. Recent advances in the treatment of systemic sclerosis. Clin Rev Allerg Immunol 36:176–200
   PubMed Web of Science ®Google Scholar
• Byung-Gyu K, Cuiling L, Wenhui Q, Mamura M, Kasperczak B, Anver M, Wolfraim L, et al. 2006. Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature 441:1015–1019
   PubMed Web of Science ®Google Scholar
• Cazac BB, Roes J. 2000. TGF-β receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13:443–451
   PubMed Web of Science ®Google Scholar
• Chang H, Brown CW, Matzuk MM. 2002. Genetic analysis of the mammalian transforming growth factor-β superfamily. Endocrine Rev 23:787–823
   PubMed Web of Science ®Google Scholar
• Chen CH, Seguin-Devaux C, Burke NA, Oriss TB, Watkins SC, Clipstone N, Ray A. 2003a. Transforming growth factor β blocks Tec kinase phosphorylation, Ca2+ influx, and NFATc translocation causing inhibition of T cell differentiation. J Exp Med 197:1689–1699
   PubMed Web of Science ®Google Scholar
• Chen WJ, Jin WW, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM. 2003b. Conversion of peripheral CD4+CD25− naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med 198:1875–1886
   PubMed Web of Science ®Google Scholar
• Chen Y-G. 2009. Endocytic regulation of TGF-β signaling. Cell Res 19:58–70
   PubMed Web of Science ®Google Scholar
• Chong MM, Rasmussen JP, Rudensky AY, Littman DR. 2008. The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. J Exp Med 205:2005–2017
   PubMed Web of Science ®Google Scholar
• Chu CQ, Field M, Abney E, Zheng RQ, Allard S, Feldmann M, Maini RN. 1991. Transforming growth factor-β1 in rheumatoid synovial membrane and cartilage/pannus junction. Clin Exp Immunol 86:380–386
   PubMed Web of Science ®Google Scholar
• Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier LL, Parsa AT. 2010. TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients. Neuro-oncology 12:7–13
   PubMed Web of Science ®Google Scholar
• Crotty S. 2011. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 29:621–663
   PubMed Web of Science ®Google Scholar
• Daïen CI, Fabre S, Rittore C, Soler S, Daïen V, Tejedor G, Cadart D, et al. 2012. TGF beta1 polymorphisms are candidate predictors of the clinical response to rituximab in rheumatoid arthritis. Joint Bone Spine 79:471–475
   PubMed Web of Science ®Google Scholar
• Daniel P, Allison S, Yiming Y, Ying-Yi Z, Laurence M. 2011. Murine models of systemic lupus erythematosus. J Biomed Biotech 2011:1–9
   Google Scholar
• Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, et al. 2008. IL-4 inhibits TGF-β-induced Foxp3+ T cells and, together with TGF-β, generates IL-9+ IL-10+ Foxp3− effector T cells. Nat Immunol 9:1347–1355
   PubMed Web of Science ®Google Scholar
• Davidson TS, DiPaolo RJ, Andersson J, Shevach EM. 2007. Cutting edge: IL-2 is essential for TGF-β-mediated induction of Foxp(3+) T regulatory cells. J Immunol 178:4022–4026
   PubMed Web of Science ®Google Scholar
• Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, Silliman N, et al. 2007. Recombinant human anti-transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum 56:323–333
   PubMed Web of Science ®Google Scholar
• Egawa T, Kreslavsky T, Littman DR, von Boehmer H. 2008. Lineage diversion of T cell receptor transgenic thymocytes revealed by lineage fate mapping. PLoS One 3:e1512
   PubMed Web of Science ®Google Scholar
• Egawa T, Littman DR. 2008. ThPOK acts late in specification of the helper T cell lineage and suppresses Runx-mediated commitment to the cytotoxic T cell lineage. Nat Immunol 9:1131–1139
   PubMed Web of Science ®Google Scholar
• Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P. 2010. The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol 10:554–567
   PubMed Web of Science ®Google Scholar
• Galliher AJ, Schiemann WP. 2007. Src phosphorylates Tyr(284) in TGF-β type II receptor and regulates TGF-β stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67:3752–3758
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, et al. 2010. Generation of pathogenic T(H)17 cells in the absence of TGF-beta signalling. Nature 467:967–971
   PubMed Web of Science ®Google Scholar
• Goodnow CC, Cyster JG, Hartley SB, Bell SE, Cooke MP, Healy JI, Akkaraju S, et al. 1995. Self-tolerance checkpoints in B lymphocyte development. Adv Immunol 59:279–368
   PubMed Web of Science ®Google Scholar
• Gorelik L, Constant S, Flavell RA. 2002. Mechanism of transforming growth factor β-induced inhibition of T helper type 1 differentiation. J Exp Med 195:1499–1505
   PubMed Web of Science ®Google Scholar
• Gorelik L, Fields PE, Flavell RA. 2000. Cutting edge: TGF-β inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165:4773–4777
   PubMed Web of Science ®Google Scholar
• Govinden R, Bhoola KD. 2003. Genealogy, expression, and cellular function of transforming growth factor-β. Pharmacol Ther 98:257–265
   PubMed Web of Science ®Google Scholar
• Gu AD, Wang Y, Lin L, Zhang SS, Wan YY. 2012. Requirements of transcription factor Smad-dependent and -independent TGF-beta signaling to control discrete T-cell functions. Proc Natl Acad Sci USA 109:905–910
   PubMed Web of Science ®Google Scholar
• Guerder S, Picarella DE, Linsley PS, Flavell RA. 1994. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor α leads to autoimmunity in transgenic mice. Proc Natl Acad Sci USA 91:5138–5142
   PubMed Web of Science ®Google Scholar
• Gutcher I, Donkor MK, Ma Q, Rudensky AY, Flavell RA, Li MO. 2011. Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. Immunity 34:396–408
   PubMed Web of Science ®Google Scholar
• Habibagahi M, Habibagahi Z, Jaberipour M, Aghdashi A. 2011. Quantification of regulatory T cells in peripheral blood of patients with systemic lupus erythematosus. Rheumatol Int 31:1219–1225
   PubMed Web of Science ®Google Scholar
• Hardy RR. 2006. B-1 B cell development. J Immunol 177:2749–2754
   PubMed Web of Science ®Google Scholar
• Haritunians T, Gueller S, O’Kelly J, Ilaria R Jr, Koeffler HP. 2008. Novel acyl sulfonamide LY573636-sodium: Effect on hematopoietic malignant cells. Oncol Rep 20:1237–1242
   PubMed Web of Science ®Google Scholar
• Harris ED Jr. 1990. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322:1277–1289
   PubMed Web of Science ®Google Scholar
• Hatton RD. 2011. TGF-beta in Th17 cell development: The truth is out there. Immunity 34:288–290
   PubMed Web of Science ®Google Scholar
• Heath VL, Murphy EE, Crain C, Tomlinson MG, O’Garra A. 2000. TGF-β1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol 30:2639–2649
   PubMed Web of Science ®Google Scholar
• Huse M, Muir TW, Xu L, Chen YG, Kuriyan J, Massague J. 2001. The TGF β receptor activation process: An inhibitor-to substrate-binding switch. Mol Cell 8:671–682
   PubMed Web of Science ®Google Scholar
• Ichiyama K, Sekiya T, Inoue N, Tamiya T, Kashiwagi I, Kimura A, Morita R, et al. 2011. Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-β is mediated by suppression of eomesodermin. Immunity 34:741–754
   PubMed Web of Science ®Google Scholar
• Ihn H. 2008. Autocrine TGF-β signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 49:103–113
   PubMed Web of Science ®Google Scholar
• Ikushima H, Miyazono K. 2010. TGFβ signalling: A complex web in cancer progression. Nat Rev Cancer 10:415–424
   PubMed Web of Science ®Google Scholar
• Ishigame H, Mosaheb MM, Sanjabi S, Flavell RA. 2013a. Truncated form of TGF-betaRII, but not its absence, induces memory CD8+ T cell expansion and lymphoproliferative disorder in mice. J Immunol 190:6340–6350
   PubMed Web of Science ®Google Scholar
• Ishigame H, Zenewicz LA, Sanjabi S, Licona-Limon P, Nakayama M, Leonard WJ, Flavell RA. 2013b. Excessive Th1 responses due to the absence of TGF-beta signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis. Proc Natl Acad Sci USA 110:6961–6966
   PubMed Web of Science ®Google Scholar
• Ivanov, II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, Finlay BB, Littman DR. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4:337–349
   PubMed Web of Science ®Google Scholar
• Jin T, Almehed K, Carlsten H, Forsblad-d’Elia H. 2012. Decreased serum levels of TGF-β1 are associated with renal damage in female patients with systemic lupus erythematosus. Lupus 21:310–318
   PubMed Web of Science ®Google Scholar
• Johnson LDS, Jameson SC. 2012. TGF-beta sensitivity restrains CD8+T cell homeostatic proliferation by enforcing sensitivity to IL-7 and IL-15. PLoS One 7:e42268
   PubMed Web of Science ®Google Scholar
• Kao H, Lin J, Littman DR, Shaw AS, Allen PM. 2008. Regulated movement of CD4 in and out of the immunological synapse. J Immunol 181:8248–8257
   PubMed Web of Science ®Google Scholar
• Kappler JW, Roehm N, Marrack P. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273–280
   PubMed Web of Science ®Google Scholar
• Kee BL, Rivera RR, Murre C. 2001. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat Immunol 2:242--247
   PubMed Web of Science ®Google Scholar
• Kim S, Buchlis G, Fridlender ZG, Sun J, Kapoor V, Cheng GJ, Haas A, et al. 2008. Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy. Cancer Res 68:10247–10256
   PubMed Web of Science ®Google Scholar
• Kirkwood JM, Gonzalez R, Reintgen D, Clingan PR, McWilliams RR, de Alwis DP, Zimmermann A, et al. 2011. A phase 2 study of tasisulam sodium (LY573636 sodium) as second-line treatment for patients with unresectable or metastatic melanoma. Cancer 117:4732–4739
   PubMed Web of Science ®Google Scholar
• Kisielow P, Blüthmann H, Staerz UD, Steinmetz M, von Boehmer H. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742–746
   PubMed Web of Science ®Google Scholar
• Konstantine IV, Roubina Ch A, Dimitrios KK, Eleftherios S, Sotirios T. 2011. TGF-β/BMPs: Crucial crossroad in neural autoimmune disorders. Neurochem Int 59:542–550
   PubMed Web of Science ®Google Scholar
• Kuwahara M, Yamashita M, Shinoda K, Tofukuji S, Onodera A, Shinnakasu R, Motohashi S, et al. 2012. The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-beta and suppresses T(H)2 differentiation. Nat Immunol 13:778–786
   PubMed Web of Science ®Google Scholar
• Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD, McClanahan T, et al. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–240
   PubMed Web of Science ®Google Scholar
• Laouar Y, Sutterwala FS, Gorelik L, Flavell RA. 2005. Transforming growth factor-β controls T helper type 1 cell development through regulation of natural killer cell interferon-γ. Nat Immunol 6:600–607
   PubMed Web of Science ®Google Scholar
• Lee JC, Lee KM, Kim DW, Heo DS. 2004. Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients. J Immunol 172:7335–7340
   PubMed Web of Science ®Google Scholar
• Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, Wu C, et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13:991–999
   PubMed Web of Science ®Google Scholar
• Li MO, Sanjabi S, Flavell RA. 2006a. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25:455–471
   PubMed Web of Science ®Google Scholar
• Li MO, Wan YY, Sanjabi S, Robertson AKL, Flavell RA. 2006b. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146
   PubMed Web of Science ®Google Scholar
• Li MO, Wan YSY, Flavell RA. 2007. T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26:579–591
   PubMed Web of Science ®Google Scholar
• Li Yang YP, Haeold LM. 2010. TGF-β and immune cells: An important regulatory axis in the tumor microenvironment and progression. Trends Immunol 31:220–227
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. 2008. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 9:632–640
   PubMed Web of Science ®Google Scholar
• Lotz M, Kekow J, Carson DA. 1990. Transforming growth factor-β and cellular immune responses in synovial fluids. J Immunol 144:4189–4194
   PubMed Web of Science ®Google Scholar
• Lucas PJ, Kim SJ, Mackall CL, Telford WG, Chu YW, Hakim FT, Gress RE. 2006. Dysregulation of IL-15-mediated T-cell homeostasis in TGF-β dominant-negative receptor transgenic mice. Blood 108:2789–2795
   PubMed Web of Science ®Google Scholar
• Lucas PJ, Kim SJ, Melby SJ, Gress RE. 2000. Disruption of T cell homeostasis in mice expressing a T cell-specific dominant negative transforming growth factor β II receptor. J Exp Med 191:1187–1196
   PubMed Web of Science ®Google Scholar
• Luci C, Reynders A, Ivanov, II, Cognet C, Chiche L, Chasson L, Hardwigsen J, et al. 2009. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat Immunol 10:75–82
   PubMed Web of Science ®Google Scholar
• Mandy JM, Daniel JC. 2008. Th17 cell differentiation: The long and winding road. Immunity 28:445–453
   PubMed Web of Science ®Google Scholar
• Manel N, Unutmaz D, Littman DR. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 9:641–649
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O’Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, et al. 2006. Transforming growth factor-β induces development of the TH17 lineage. Nature 441:231–234
   PubMed Web of Science ®Google Scholar
• Marie JC, Letterio JJ, Gavin M, Rudensky AY. 2005. TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201:1061–1067
   PubMed Web of Science ®Google Scholar
• Massague J. 1998. TGF-β signal transduction. Annu Rev Biochem 67:753–791
   PubMed Web of Science ®Google Scholar
• Massagué J. 2008. TGFβ in Cancer. Cell 134:215–230
   PubMed Web of Science ®Google Scholar
• McCarron MJ, Marie JC. 2014. TGF-beta prevents T follicular helper cell accumulation and B cell autoreactivity. J Clin Invest 124:4375–4386
   PubMed Web of Science ®Google Scholar
• Ming OL, Richard AF. 2008. TGF-β: A master of all T cell trades. Cell 134:392–404
   PubMed Web of Science ®Google Scholar
• Mu YB, Gudey SK, Landstrom M. 2012. Non-Smad signaling pathways. Cell Tissue Res 347:11–20
   PubMed Web of Science ®Google Scholar
• Munoz O, Fend F, de Beaumont R, Husson H, Astier A, Freedman AS. 2004. TGFβ-mediated activation of Smad1 in B-cell non-Hodgkin’s lymphoma and effect on cell proliferation. Leukemia 18:2015–2025
   PubMed Web of Science ®Google Scholar
• Murphy KM, Reiner SL. 2002. The lineage decisions of helper T cells. Nat Rev Immunol 2:933–944
   PubMed Web of Science ®Google Scholar
• Nakano K, Higashi T, Hashimoto K, Takagi R, Tanaka Y, Matsushita S. 2008. Antagonizing dopamine D1-like receptor inhibits Th17 cell differentiation: Preventive and therapeutic effects on experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun 373:286–291
   PubMed Web of Science ®Google Scholar
• Norbert G, David HB. 2007. Gender as risk factor for autoimmune diseases. J Autoimmun 28:1–6
   PubMed Web of Science ®Google Scholar
• Pang Y, Gara SK, Achyut BR, Li Z, Yan HH, Day CP, Weiss JM, et al. 2013. TGF-beta signaling in myeloid cells is required for tumor metastasis. Cancer Discov 3:936–951
   PubMed Web of Science ®Google Scholar
• Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang Y-H, Wang Y, et al. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–1141
   PubMed Web of Science ®Google Scholar
• Penafuerte C, Bautista-Lopez N, Bouchentouf M, Birman E, Forner K, Galipeau J. 2011. Novel TGF-beta antagonist inhibits tumor growth and angiogenesis by inducing IL-2 receptor-driven STAT1 activation. J Immunol 186:6933–6944
   PubMed Web of Science ®Google Scholar
• Penafuerte C, Ng S, Bautista-Lopez N, Birman E, Forner K, Galipeau J. 2012. B effector cells activated by a chimeric protein consisting of IL-2 and the ectodomain of TGF-beta receptor II induce potent antitumor immunity. Cancer Res 72:1210–1220
   PubMed Web of Science ®Google Scholar
• Pohlers D, Beyer A, Koczan D, Wilhelm T, Thiesen HJ, Kinne RW. 2007. Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther 9:R59
   PubMed Web of Science ®Google Scholar
• Quezada SA, Peggs KS, Simpson TR, Shen Y, Littman DR, Allison JP. 2008. Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. J Exp Med 205:2125–2138
   PubMed Web of Science ®Google Scholar
• Ramalingam R, Larmonier CB, Thurston RD, Midura-Kiela MT, Zheng SG, Ghishan FK, Kiela PR. 2012. Dendritic cell-specific disruption of TGF-beta receptor II leads to altered regulatory T cell phenotype and spontaneous multiorgan autoimmunity. J Immunol 189:3878–3893
   PubMed Web of Science ®Google Scholar
• Raz E, Dudler J, Lotz M, Baird SM, Berry CC, Eisenberg RA, Carson DA. 1995. Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 4:286–292
   PubMed Web of Science ®Google Scholar
• Sakaguchi S. 2004. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531–562
   PubMed Web of Science ®Google Scholar
• Scandella E, Bolinger B, Lattmann E, Miller S, Favre S, Littman DR, Finke D, et al. 2008. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat Immunol 9:667–675
   PubMed Web of Science ®Google Scholar
• Schmitt N, Liu Y, Bentebibel SE, Munagala I, Bourdery L, Venuprasad K, Banchereau J, Ueno H. 2014. The cytokine TGF-beta co-opts signaling via STAT3-STAT4 to promote the differentiation of human TFH cells. Nat Immunol 15:856–865
   PubMed Web of Science ®Google Scholar
• Shashi A, Ameeta P, Padmaja M. 2012. Sex differences and genomics in autoimmune diseases. J Autoimmun 38:J254–J265
   PubMed Web of Science ®Google Scholar
• Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, Springer TA. 2011. Latent TGF-beta structure and activation. Nature 474:343–349
   PubMed Web of Science ®Google Scholar
• Shi YG, Massague J. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113:685–700
   PubMed Web of Science ®Google Scholar
• Simon GR, Ilaria RL Jr, Sovak MA, Williams CC, Haura EB, Cleverly AL, Sykes AK, et al. 2011. A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors. Cancer Chemother Pharmacol 68:1233–1241
   PubMed Web of Science ®Google Scholar
• Stephen TL, Rutkowski MR, Allegrezza MJ, Perales-Puchalt A, Tesone AJ, Svoronos N, Nguyen JM, et al. 2014. Transforming growth factor beta-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression. Immunity 41:427–439
   PubMed Web of Science ®Google Scholar
• Surh CD, Sprent J. 2012. TGF-beta puts the brakes on homeostatic proliferation. Nat Immunol 13:628–630
   PubMed Web of Science ®Google Scholar
• Takatori H, Kanno Y, Watford WT, Tato CM, Weiss G, Ivanov, II, Littman DR, O’Shea JJ. 2009. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 206:35–41
   PubMed Web of Science ®Google Scholar
• Tassi I, Cella M, Presti R, Colucci A, Gilfillan S, Littman DR, Colonna M. 2008. NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion. Blood 112:4109–4116
   PubMed Web of Science ®Google Scholar
• Terabe M, Ambrosino E, Takaku S, O’Konek JJ, Venzon D, Lonnin S, McPherson JM, Berzofsky JA. 2009. Synergistic enhancement of CD8(+) T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-β monoclonal antibody. Cancer Res 15:6560–6569
   Web of Science ®Google Scholar
• Terabe M, Matsui S, Park JM, Mamura M, Noben-Trauth N, Donaldson DD, Chen WJ, et al. 2003. Transforming growth factor-β production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: Abrogation prevents tumor recurrence. J Exp Med 198:1472–1752
   Web of Science ®Google Scholar
• Thiery JP. 2002. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442–454
   PubMed Web of Science ®Google Scholar
• Thorbecke GJ, Shah R, Leu CH, Kuruvilla AP, Hardison AM, Palladino MA. 1992. Involvement of endogenous tumor necrosis factor a and transforming growth factor β during induction of collagen type II arthritis in mice. Proc Nat Acad Sci USA 89:7375–7379
   PubMed Web of Science ®Google Scholar
• Tsuji M, Suzuki K, Kitamura H, Maruya M, Kinoshita K, Ivanov, II, Itoh K, et al. 2008. Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 29:261–271
   PubMed Web of Science ®Google Scholar
• Veldhoen M, Hocking RJ, Flavell RA, Stockinger B. 2006. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7:1151–1156
   PubMed Web of Science ®Google Scholar
• Wahl SM. 1994. Transforming growth factor β: The good, the bad, and the ugly. J Exp Med 180:1587–1590
   PubMed Web of Science ®Google Scholar
• Wahl SM, Allen JB, Costa GL, Wong HL, Dasch JR. 1993. Reversal of acute and chronic synovial inflammation by anti-transforming growth factor-β. J Exp Med 177:225–230
   PubMed Web of Science ®Google Scholar
• Wahl SM, Wen J, Moutsopoulos N. 2006. TGF-b: A mobile purveyor of immune privilege. Immunol Rev 213:213–227
   PubMed Web of Science ®Google Scholar
• Werner F, Jain MK, Feinberg MW, Sibinga NES, Pellacani A, Wiesel P, Chin MT, et al. 2000. Transforming growth factor-β1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem 275:36653–36658
   PubMed Web of Science ®Google Scholar
• Wrana JL, Attisano L, Wieser R, Ventura F, Massague J. 1994. Mechanism of activation of TGF-β receptor. Nature 370:341–347
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Patel M, Harper A, Bonito A, Fukuyama H, Pack M, Tarbell KV, et al. 2006. Effective expansion of alloantigen-specific Foxp3+CD25+CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci USA 103:2758–2763
   PubMed Web of Science ®Google Scholar
• Yang H, Cheng EY, Sharma VK, Lagman M, Chang C, Song P, Ding R, et al. 2012. Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells. Transplantation 93:580–588
   PubMed Web of Science ®Google Scholar
• Yang L, Huang JH, Ren XB, Gorska AE, Chytil A, Aakre M, Carbone DP, et al. 2008. Abrogation of TGF β signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13:23–35
   PubMed Web of Science ®Google Scholar
• Yang L, Moses HL. 2008. Transforming growth factor b: Tumor suppressor or promoter? Are host immune cells the answer? Cancer Res 68:9107–9111
   PubMed Web of Science ®Google Scholar
• Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C. 1999. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 18:1280–1291
   PubMed Web of Science ®Google Scholar
• Yaswen L, Kulkarni AB, Fredrickson T, Mittleman B, Schiffman R, Payne S, Longenecker G, et al. 1996. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood 87:1439–1445
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Wakabayashi Y, Mori T. 2010. Cellular and molecular basis for the regulation of inflammation by TGF-β. J Biochem 147:781–792
   PubMed Web of Science ®Google Scholar
• Yu CI, Becker C, Wang Y, Marches F, Helft J, Leboeuf M, Anguiano E, et al. 2013. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector T cells via the cytokine TGF-beta. Immunity 38:818–830
   PubMed Web of Science ®Google Scholar
• Zhang JX, Diehl GE, Littman DR. 2008. Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells. PLoS One 3:e2035
   PubMed Web of Science ®Google Scholar
• Zhang N, Bevan MJ. 2012. TGF-beta signaling to T cells inhibits autoimmunity during lymphopenia-driven proliferation. Nat Immunol 13:667–673
   PubMed Web of Science ®Google Scholar
• Zhou L, Lopes JE, Chong MM, Ivanov, II, Min R, Victora GD, Shen Y, et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453:236–240
   PubMed Web of Science ®Google Scholar
• Zhu HJ, Burgess AW. 2001. Regulation of transforming growth factor-beta signaling. Mol Cell Biol Res Commun 4:321–330
   PubMedGoogle Scholar
• Zi Z, Chapnick DA, Liu X. 2012. Dynamics of TGF-β/Smad signaling. FEBS Lett 586:1921–1928
   PubMed Web of Science ®Google Scholar